This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Molecular Imaging Market

Increasing preference for non-invasive and pain free surgeries to encourage Molecular Imaging uptake in the coming decade

Molecular Imaging Market by Modality, End User, Application & Region - Forecast 2022 - 2032

Molecular Imaging Market Snapshot (2022-2032)

[301 Pages Report] The global molecular imaging market is expected to secure US$ 4.31 Billion in 2022. During the forecast period of 2022-2032, the market is projected to exhibit a CAGR of 5.41% while garnering US$ 7.3 Billion. The growth of the market can be attributed to the increasing incidences of chronic illness across the globe.

The increasing prevalence of chronic diseases like cancer and other genetic illness are expected to propel the demand for an efficient and early disease diagnosis, which is projected to benefit the global molecular imaging market during the forecast period.

Increasing adoption of molecular imaging for new applications, ongoing development and innovation in molecular imaging technologies, and developing economies are likely to provide significant opportunities for growth in the market in the coming time.

Data Points

Key Statistics

Expected Market Value (2022)

US$ 4.31 Billion

Anticipated Forecast Value (2032)

US$ 7.3 Billion

Projected Growth Rate (2022-2032)

5.41%

Furthermore, molecular imaging procedures have various benefits which are projected to augment the molecular imaging market. Molecular imaging procedures are non-invasive, safe, and painless and are used to treat heart diseases, cancer, and disorders like Alzheimer’s and Parkinson’s disease, kidney and thyroid disorders, and others. Early detection of the diseases allows treatment on time when there may be a better prognosis.

Additionally, the introduction of new devices is likely to augment the market size during the forecast period. In January 2021, Molecular Devices LLC., a renowned provider of high-performance life science technology, launched its next-generation, high-content imaging system.

The new system provides faster image acquisition and multiplexing flexibility with high-performance lasers. Image analysis with machine learning will allow researchers to quickly uncover new insights that are provable and repeatable with clarity, and accuracy. Such initiatives are expected to benefit the market growth in the forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

Global Molecular Imaging Market Revenue Analysis 2017-2021 Vs Future Outlook 2022-2032

From 2017-2021, the global molecular imaging market is expected to have displayed a CAGR of 4.8%. Expansion during the given time frame can be attributed to the growing demand for early detection tools, growth initiatives, and reimbursement initiatives undertaken by the government.

Also, the introduction of advanced equipment is another factor that is likely to have participated in market development. For instance, in August 2020, Philips expanded its cardiovascular ultrasound portfolio by launching Affiniti CVs. Attributed to such factors, the market is likely to have displayed growth opportunities in the aforementioned forecast period.

During the forecast period of 2022-2032, the global molecular imaging market is anticipated to display a CAGR of 5.14%. The development of the market can be attributed to the introduction of advanced technologies. For instance, in 2021, GE Healthcare, a US-based player, launched Venue Fit.

It is a streamlined and compact POCUS system, along with the industry’s first AI offering for cardiology. Such initiatives are expected to benefit the market during the assessment tenure.

What Are The Prominent Factors In The Global Molecular Imaging Market?

Introduction of Advanced Equipment to Favor Market Growth

Increasing demand for early detection and cost-effective diagnosis of chronic diseases along with the rising geriatric population across the globe are likely to fuel demand for the molecular imaging system. The advent of modern devices and developing healthcare infrastructure in evolving economies are some of the salient factors escalating market growth.

The launch of AI-based devices is projected to augment the market size in the coming time. For instance, in May 2020, Fujifilm Corporation launched AI-based technology for lung nodule detection. This technology is used to detect pulmonary nodules in chest CT scans to aid in lung cancer detection.

In another instance, in November 2020, Canon Medical Systems Corporation launched One-Beat Spectral Cardiac CT, with rapid kVp switching and deep learning spectral reconstruction to acquire whole-heart spectral images in one beat. Thus, the launch of advanced products is anticipated to benefit the industry during the forecast period.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What Are The Factors Hindering The Global Molecular Imaging Market?

Expenses Associated with Molecular Imaging System to Hinder the Market

High expenses associated with advanced molecular imaging system is projected to hamper the market growth during the forecast period. The presence of unfavorable reimbursements and lack of expertise in developing countries can hinder the market growth.

However, the rapid growth of the geriatric population, and growing cases of Alzheimer’s disease, arthritis, dementia, and Parkinson’s disease, are expected to escalate the demand for molecular imaging devices, thus, benefitting the industry in the forecast period.

What Are The Key Trends In The Global Molecular Imaging Market?

AI-Based Medical Equipment to Offer Remunerative Opportunities to the Molecular Imaging Market

The increasing application of AI-based diagnostic equipment for the rapid detection of illnesses is anticipated to act as a significant opportunity for the global molecular imaging market during the forecast period. Players in the market are introducing AI-based equipment which will help the market in fetching significant dividends.

In 2019, Siemens Healthineers introduced an ultrasound system, Acuson Redwood, which provides an imaging solution for clinical departments including cardiology, radiology, and gynecology.

Also, growing approvals of products by authorities can further benefit the market. For instance, in December 2020, Hologic, Inc., announced that the U.S FDA had approved Genius AI Detection technology for early detection of breast cancer. The advent of AI-based devices is projected to benefit the market in the coming time.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Segmentation Analysis

Why is the Hospital Segment Dominating the Global Molecular Imaging Market?

Availability of Modern Equipment in Hospitals to Boost the Segment Growth

As per the analysis, based on end-users, the hospital segment is anticipated to dominate the global molecular imaging market. In 2021, the segment is projected to have claimed 46.5% of the global revenue.

Increasing demand for modern techniques and the availability of advanced services are likely to benefit the segmental growth during the forecast period. Developed countries have shown a significant rise in demand for such setups. Attributed to such factors, the segment is projected to grow significantly in the forecast period.

What is the Participation of Diagnostic Centers to Augment the Global Molecular Imaging Market?

Growing Demand for On-time Disease Detection to Propel the Segment Growth

Increasing demand for on-time detection and treatment of diseases is expected to benefit the molecular diagnostic segment during the forecast period. The growing number of diagnostic centers owing to consolidation in the market is likely to contribute to the segmental growth in the forecast period.

Furthermore, increasing adoption of advanced technology and developed infrastructure are other factors contributing to the development of the segment.

Regional Analysis

How are Increasing Product Launches Strengthening the Molecular Imaging Market in North America?

According to the analysis, the global molecular imaging market is projected to be dominated by North America during the forecast period. In 2021, the region is likely to have accounted for the largest market share of about 33%. Domination of the region can be attributed to the presence of established players in the region taking various initiatives to launch new products.

Further, growing clearances of the product by the FDA are likely to widen the market growth scope in the coming time. For instance, in January 2019, United Imaging Healthcare announced the US FDA of uEXPLORER total-body scanner. It is the globe’s first medical imaging scanner that can capture a 3D image of the human body. Such factors are expected to benefit the global molecular imaging market.

How is Growing Technological Advancement Developing the Molecular Imaging Market in Europe?

According to the analysis, the market for molecular imaging in Europe is anticipated to display a CAGR of 4% during the forecast period. Development of the market can be attributed to the ongoing technological development in the market. For instance, in 2021, Koninklijke Philips launched the spectral detector-based Spectral Computed Tomography (CT) 7500 solution for accurate diagnosis.

Players receiving FDA clearances is another salient factor that is likely to develop the industry in the forecast period. For instance, in 2021, Siemens Healthineers received FDA clearance for the Biograph Vision Quadra, a CT scanner for clinical application. Such factors are likely to make a significant contribution to developing the market in Europe.

How is the Rising Demand for Imaging Equipment Benefitting the Global Molecular Imaging Market?

According to the analysis, APAC is projected to be the fastest-growing market for molecular imaging market during the forecast period. The region is likely to display a CAGR of 6% during the timeframe of 2022-2032.

The development of the regional market can be attributed to the increasing prevalence of chronic illness and the growing demand for developed diagnostic devices. Further, the rapid growth of healthcare infrastructure in evolving countries is another salient factor that can strengthen the industry in the coming time.

What Is The Role Of Startups In Developing The Global Molecular Imaging Market?

VoxelCloud (US), Aldoc (Israel), Qure.ai (India), Zebra Medical Vision (Israel), HeartFlow (US), Arterys (US), Kheiron Medical Technologies (UK), and Lunit (South Korea), among others, are some of the emerging names in the global molecular imaging market.

Recent Updates from the Startup Landscape:

  • In March 2022, Healthtech Startup Qure.ai raised US$ 40 Million in a funding round led by Novo Holdings and HealthQuad. The existing investor MassMutual Ventures also participated in the round. The capital will be used to strengthen its reach in the US and Europe.

Competition Analysis

Key players in the global molecular imaging market include Hermes Medical Solutions, Bruker Corporation, GE Company, Fujifilm Holdings Corp., Siemens AG, Koninklijke Philips N.V., and Toshiba Medical System Corp.

Recent Developments in the Market:

  • In September 2021, Hermes Medical Solutions and Isotopia Molecular Imaging announced a new collaboration with Isotopia to raise awareness and co-promote the benefits of dosimetry, personalized medicine, and radiopharmaceutical therapy.
  • In February 2021, Royal Philips announced the acquisition of BioTelemetry, a US-based player that provides remote cardiac diagnostics and monitoring. The acquisition of BioTelemetry is a strong fit with Philips’ cardiac care portfolio, and its strategy to transform the delivery of care along the health continuum with integrated solutions.

Scope Of The Report

Attribute

Details

Molecular Imaging Market Forecast Period

2022-2032

Molecular Imaging Market Historical Data Available for

2017-2021

Molecular Imaging Market Analysis

USD Million for Value and Volume in Units

Molecular Imaging Market - Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA

Molecular Imaging Market - Key Countries Covered

U.S., Canada, Brazil, U.K., Mexico, Germany, France, Italy, Spain, BENELUX, Russia, Japan, India, China, Japan, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC, and South Africa

Molecular Imaging Market - Key Segments Covered

Modality, Application, End User, Region

Molecular Imaging Market - Key Companies Profiled

  • Hermes Medical Solutions
  • Bruker Corporation
  • GE Company
  • Fujifilm Holdings Corp.
  • Koninklijke Philips N.V.
  • Siemens AG
  • Toshiba Medical System Corp.
  • Mirada Medical Limited
  • Carestream Health, Inc.
  • Esaote SpA
  • Positron Corporation
  • Medisco Ltd.
  • Hitachi Medical Corp.
  • MIM Software Inc.

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Frequently Asked Questions

The global molecular imaging market is expected to secure US$ 4.309 Billion in 2022.

The global molecular imaging market is expected to value at US$ 7.3 Billion by 2032.

The global molecular imaging market is likely to exhibit a CAGR of 5.41% during the forecast period.

In Europe, the molecular imaging market is expected to display a CAGR of 4% during the forecast period.

In 2021, the hospital segment is projected to have secured 46.5% of the global revenue.

In APAC, the molecular imaging market is expected to display a CAGR of 6% during the forecast period.

In 2021, the molecular imaging market in North America is expected to have claimed 33% of the global revenue.

Hermes Medical Solutions, Bruker Corporation, and GE Company are some of the renowned players in the global molecular imaging market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusion

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption / Usage Analysis

    4.2. Strategic promotional strategies

5. COVID-19 Crisis Analysis

    5.1. Current COVID19 Statistics and Probable Future Impact

    5.2. Current GDP Projection and Probable Impact

    5.3. Current Economic Projection as compared to 2008 financial analysis

    5.4. COVID19 and Impact Analysis, by Country

    5.5. 2022 Market Scenario

    5.6. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Global Market Volume (‘000’ Units) Analysis 2017-2021 and Forecast, 2022-2032

    6.1. Historical Market Volume (‘000’ Units) Analysis, 2017-2021

    6.2. Current and Future Market Volume (‘000’ Units) Projections, 2022-2032

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market - Pricing Analysis, 2022-2032

    7.1. Regional Pricing Analysis By Modality

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

    8.1. Historical Market Value (US$ Mn) Analysis, 2017-2021

    8.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Market Background

    9.1. Macro-Economic Factors

        9.1.1. Global GDP Growth Outlook

        9.1.2. Global Healthcare Expenditure Outlook

        9.1.3. Income Per Capita Outlook

    9.2. Forecast Factors - Relevance & Impact

        9.2.1. Investment in medical infrastructure development

        9.2.2. Emergence of alternative devices

        9.2.3. Growth in commercial diagnostics application

        9.2.4. Government support medical device research and development

        9.2.5. Changing lifestyles

        9.2.6. Epidemiology of cancer and other chronic diseases

    9.3. Market Dynamics

        9.3.1. Drivers

        9.3.2. Restraints

        9.3.3. Opportunity Analysis

10. Global Market Analysis 2017-2021 and Forecast, 2022-2032, by Modality

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Modality, 2017-2021

    10.3. Current and Future Market Size (US$ Mn) and Volume Units Analysis and Forecast By Modality, 2021 - 2031

        10.3.1. Positron Emission Tomography (PET)

        10.3.2. Positron Emission Tomography- Computed Tomography (PET-CT)

        10.3.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)

        10.3.4. Single Photon Emission Computed Tomography (SPECT)

        10.3.5. Software

            10.3.5.1. On Premises Solutions

            10.3.5.2. Cloud Based Solutions

        10.3.6. Magnetic Resonance

        10.3.7. Molecular Ultrasound Imaging

    10.4. Market Attractiveness Analysis By Modality

11. Global Market Analysis 2017-2021 and Forecast, 2022-2032, by Application

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Application, 2017-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032

        11.3.1. Cardiology

        11.3.2. Oncology

        11.3.3. Gastrointestinal Disorders

        11.3.4. Neurology Disorders

        11.3.5. Others

    11.4. Market Attractiveness Analysis By Application

12. Global Market Analysis 2017-2021 and Forecast, 2022-2032, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032

        12.3.1. Hospitals

            12.3.1.1. 500+ Beds

            12.3.1.2. 200-499 Beds

            12.3.1.3. Less than 200 Beds

        12.3.2. Ambulatory Surgical Centres

        12.3.3. Diagnostic Centres

    12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2017-2021 and Forecast, 2022-2032, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021

    13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. MEA

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2017-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.3.1. By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Modality

        14.3.3. By Application

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Latin America Market Analysis 2017-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        15.3.1. By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Modality

        15.3.3. By Application

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Europe Market Analysis 2017-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. Russia

            16.3.1.7. Rest of Europe

        16.3.2. By Modality

        16.3.3. By Application

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. South Asia Market Analysis 2017-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.2. By Modality

        17.3.3. By Application

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. East Asia Market Analysis 2017-2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

            18.3.1.4. Rest of East Asia

        18.3.2. By Modality

        18.3.3. By Application

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Oceania Market Analysis 2017-2021 and Forecast 2022-2032

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Modality

        19.3.3. By Application

        19.3.4. By End User

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Market Analysis 2017-2021 and Forecast 2022-2032

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021

    20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Turkey

            20.3.1.3. South Africa

            20.3.1.4. Rest of Middle East and Africa

        20.3.2. By Modality

        20.3.3. By Application

        20.3.4. By End User

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Key and Emerging Countries Market Analysis 2017-2021 and Forecast 2022-2032

    21.1. Introduction

        21.1.1. Market Value Proportion Analysis, By Key Countries

        21.1.2. Global Vs. Country Growth Comparison

    21.2. U.S. Market Analysis

        21.2.1. By Modality

        21.2.2. By Application

        21.2.3. By End User

    21.3. Canada Market Analysis

        21.3.1. By Modality

        21.3.2. By Application

        21.3.3. By End User

    21.4. Mexico Market Analysis

        21.4.1. By Modality

        21.4.2. By Application

        21.4.3. By End User

    21.5. Brazil Market Analysis

        21.5.1. By Modality

        21.5.2. By Application

        21.5.3. By End User

    21.6. U.K. Market Analysis

        21.6.1. By Modality

        21.6.2. By Application

        21.6.3. By End User

    21.7. Germany Market Analysis

        21.7.1. By Modality

        21.7.2. By Application

        21.7.3. By End User

    21.8. France Market Analysis

        21.8.1. By Modality

        21.8.2. By Application

        21.8.3. By End User

    21.9. Italy Market Analysis

        21.9.1. By Modality

        21.9.2. By Application

        21.9.3. By End User

    21.10. Spain Market Analysis

        21.10.1. By Modality

        21.10.2. By Application

        21.10.3. By End User

    21.11. BENELUX Market Analysis

        21.11.1. By Modality

        21.11.2. By Application

        21.11.3. By End User

    21.12. Russia Market Analysis

        21.12.1. By Modality

        21.12.2. By Application

        21.12.3. By End User

    21.13. Poland Market Analysis

        21.13.1. By Modality

        21.13.2. By Application

        21.13.3. By End User

    21.14. China Market Analysis

        21.14.1. By Modality

        21.14.2. By Application

        21.14.3. By End User

    21.15. Japan Market Analysis

        21.15.1. By Modality

        21.15.2. By Application

        21.15.3. By End User

    21.16. South Korea Market Analysis

        21.16.1. By Modality

        21.16.2. By Application

        21.16.3. By End User

    21.17. India Market Analysis

        21.17.1. By Modality

        21.17.2. By Application

        21.17.3. By End User

    21.18. ASEAN Market Analysis

        21.18.1. By Modality

        21.18.2. By Application

        21.18.3. By End User

    21.19. Australia Market Analysis

        21.19.1. By Modality

        21.19.2. By Application

        21.19.3. By End User

    21.20. New Zealand Market Analysis

        21.20.1. By Modality

        21.20.2. By Application

        21.20.3. By End User

    21.21. GCC Countries Market Analysis

        21.21.1. By Modality

        21.21.2. By Application

        21.21.3. By End User

    21.22. South Africa Market Analysis

        21.22.1. By Modality

        21.22.2. By Application

        21.22.3. By End User

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies

    22.2. Market Share Analysis of Top Players

    22.3. Competition Intensity Mapping By Market Taxonomy

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive

        23.3.1. GE Company

            23.3.1.1. Overview

            23.3.1.2. Product Portfolio

            23.3.1.3. Financial Overview

            23.3.1.4. Strategy Overview

            23.3.1.5. SWOT

            23.3.1.6. Key Developments

        23.3.2. Fujifilm Holdings Corporation

            23.3.2.1. Overview

            23.3.2.2. Product Portfolio

            23.3.2.3. Financial Overview

            23.3.2.4. Strategy Overview

            23.3.2.5. SWOT

            23.3.2.6. Key Developments

        23.3.3. Siemens AG

            23.3.3.1. Overview

            23.3.3.2. Product Portfolio

            23.3.3.3. Financial Overview

            23.3.3.4. Strategy Overview

            23.3.3.5. SWOT

            23.3.3.6. Key Developments

        23.3.4. Koninklijke Philips N.V.

            23.3.4.1. Overview

            23.3.4.2. Product Portfolio

            23.3.4.3. Financial Overview

            23.3.4.4. Strategy Overview

            23.3.4.5. SWOT

            23.3.4.6. Key Developments

        23.3.5. Toshiba Medical System Corp.

            23.3.5.1. Overview

            23.3.5.2. Product Portfolio

            23.3.5.3. Financial Overview

            23.3.5.4. Strategy Overview

            23.3.5.5. SWOT

            23.3.5.6. Key Developments

        23.3.6. Hitachi Medical Corp.

            23.3.6.1. Overview

            23.3.6.2. Product Portfolio

            23.3.6.3. Financial Overview

            23.3.6.4. Strategy Overview

            23.3.6.5. SWOT

            23.3.6.6. Key Developments

        23.3.7. Medisco Ltd.

            23.3.7.1. Overview

            23.3.7.2. Product Portfolio

            23.3.7.3. Financial Overview

            23.3.7.4. Strategy Overview

            23.3.7.5. SWOT

            23.3.7.6. Key Developments

        23.3.8. Positrion Corporation

            23.3.8.1. Overview

            23.3.8.2. Product Portfolio

            23.3.8.3. Financial Overview

            23.3.8.4. Strategy Overview

            23.3.8.5. SWOT

            23.3.8.6. Key Developments

        23.3.9. Esaote SpA

            23.3.9.1. Overview

            23.3.9.2. Product Portfolio

            23.3.9.3. Financial Overview

            23.3.9.4. Strategy Overview

            23.3.9.5. SWOT

            23.3.9.6. Key Developments

        23.3.10. Carestream Health Inc.

            23.3.10.1. Overview

            23.3.10.2. Product Portfolio

            23.3.10.3. Financial Overview

            23.3.10.4. Strategy Overview

            23.3.10.5. SWOT

            23.3.10.6. Key Developments

        23.3.11. Mirada Medical Limited

            23.3.11.1. Overview

            23.3.11.2. Product Portfolio

            23.3.11.3. Financial Overview

            23.3.11.4. Strategy Overview

            23.3.11.5. SWOT

            23.3.11.6. Key Developments

        23.3.12. MIM Software Inc.

            23.3.12.1. Overview

            23.3.12.2. Product Portfolio

            23.3.12.3. Financial Overview

            23.3.12.4. Strategy Overview

            23.3.12.5. SWOT

            23.3.12.6. Key Developments

        23.3.13. Bruker Corporation

            23.3.13.1. Overview

            23.3.13.2. Product Portfolio

            23.3.13.3. Financial Overview

            23.3.13.4. Strategy Overview

            23.3.13.5. SWOT

            23.3.13.6. Key Developments

        23.3.14. Hermes Medical Solutions

            23.3.14.1. Overview

            23.3.14.2. Product Portfolio

            23.3.14.3. Financial Overview

            23.3.14.4. Strategy Overview

            23.3.14.5. SWOT

            23.3.14.6. Key Developments

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Demand (in Volume 000'Units) Analysis- and Opportunity Assessment 2017-2032, By Modality

Table 02: Global Market Value (US$ Mn) Analysis- and Opportunity Assessment 2017-2032, By Modality

Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017-2032, By Application

Table 04: Global Market Value (US$ Mn) Analysis- and Opportunity Assessment 2017-2032, By End User

Table 05: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017-2032, By Region

Table 06: North America Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 07: North America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 08: North America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application

Table 09: North America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

Table 10: North America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country

Table 11: Latin America Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 12: Latin America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 13: Latin America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application

Table 14: Latin America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

Table 15: Latin America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country

Table 16: Europe Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 17: Europe Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 18: Europe Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application

Table 19: Europe Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

Table 20: Europe Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country

Table 21: South Asia Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 22: South Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 23: South Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application

Table 24: South Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

Table 25: South Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country

Table 26: East Asia Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 27: East Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 28: East Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application

Table 29: East Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

Table 30: East Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country

Table 31: Oceania Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 32: Oceania Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 33: Oceania Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application

Table 34: Oceania Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

Table 35: Oceania Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country

Table 36: Middle East and Africa Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 37: Middle East and Africa Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality

Table 38: Middle East and Africa Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application

Table 39: Middle East and Africa Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User

Table 40: Middle East and Africa Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Historical Market Volume Analysis, 2017-2021

Figure 02: Country Average Pricing Analysis Benchmark USD/ Per Unit (2022)

Figure 03: Global Current and Future Market Volume, 2022-2032 & Y-o-Y Growth Trend Analysis

Figure 04: Global Market Value Analysis (US$ Mn), 2017-2021

Figure 05: Global Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032

Figure 06: Global Market Absolute $ Opportunity, 2022-2032

Figure 07: Global Market Share Analysis (%), By Modality, 2022 & 2032

Figure 08: Global Market Y-o-Y Analysis (%), By Modality, 2022-2032

Figure 09: Global Market Attractiveness Analysis by Modality, 2022-2032

Figure 10: Global Market Share Analysis (%), By Application, 2022 & 2032

Figure 11: Global Market Y-o-Y Analysis (%), By Application, 2022-2032

Figure 12: Global Market Attractiveness Analysis by Application, 2022-2032

Figure 13: Global Market Share Analysis (%), By End User, 2022 & 2032

Figure 14: Global Market Y-o-Y Analysis (%), By End User, 2022-2032

Figure 15: Global Market Attractiveness Analysis by End User, 2022-2032

Figure 16: Global Market Share Analysis (%), By Region, 2022 & 2032

Figure 17: Global Market Y-o-Y Analysis (%), By Region, 2022-2032

Figure 18: Global Market Attractiveness Analysis by Region, 2022-2032

Figure 19: North America Market Value Analysis (US$ Mn), 2017-2021

Figure 20: North America Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032

Figure 21: North America Market Share, By Modality (2022)

Figure 22: North America Market Share, By End User (2022)

Figure 23: North America Market Share, By Application (2022)

Figure 24: North America Market Share, By Country (2022)

Figure 25: North America Market Attractiveness Analysis by Modality, 2022-2032

Figure 26: North America Market Attractiveness Analysis by Application, 2022-2032

Figure 27: North America Market Attractiveness Analysis by End User, 2022-2032

Figure 28: North America Market Attractiveness Analysis by Country, 2022-2032

Figure 29: Latin America Market Value Analysis (US$ Mn), 2017-2021

Figure 30: Latin America Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032

Figure 31: Latin America Market Share, By Modality (2022)

Figure 32: Latin America Market Share, By End User (2022)

Figure 33: Latin America Market Share, By Application (2022)

Figure 34: Latin America Market Share, By Country (2022)

Figure 35: Latin America Market Attractiveness Analysis by Modality, 2022-2032

Figure 36: Latin America Market Attractiveness Analysis by Application, 2022-2032

Figure 37: Latin America Market Attractiveness Analysis by End User, 2022-2032

Figure 38: Latin America Market Attractiveness Analysis by Country, 2022-2032

Figure 39: Europe Market Value Analysis (US$ Mn), 2017-2021

Figure 40: Europe Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032

Figure 41: Europe Market Share, By Modality (2022)

Figure 42: Europe Market Share, By End User (2022)

Figure 43: Europe Market Share, By Application (2022)

Figure 44: Europe Market Share, By Country (2022)

Figure 45: Europe Market Attractiveness Analysis by Modality, 2022-2032

Figure 46: Europe Market Attractiveness Analysis by Application, 2022-2032

Figure 47: Europe Market Attractiveness Analysis by End User, 2022-2032

Figure 48: Europe Market Attractiveness Analysis by Country, 2022-2032

Figure 49: South Asia Market Value Analysis (US$ Mn), 2017-2021

Figure 50: South Asia Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032

Figure 51: South Asia Market Share, By Modality (2022)

Figure 52: South Asia Market Share, By End User (2022)

Figure 53: South Asia Market Share, By Application (2022)

Figure 54: South Asia Market Share, By Country (2022)

Figure 55: South Asia Market Attractiveness Analysis by Modality, 2022-2032

Figure 56: South Asia Market Attractiveness Analysis by Application, 2022-2032

Figure 57: South Asia Market Attractiveness Analysis by End User, 2022-2032

Figure 58: South Asia Market Attractiveness Analysis by Country, 2022-2032

Figure 59: East Asia Market Value Analysis (US$ Mn), 2017-2021

Figure 60: East Asia Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032

Figure 61: East Asia Market Share, By Modality (2022)

Figure 62: East Asia Market Share, By End User (2022)

Figure 63: East Asia Market Share, By Application (2022)

Figure 64: East Asia Market Share, By Country (2022)

Figure 65: East Asia Market Attractiveness Analysis by Modality, 2022-2032

Figure 66: East Asia Market Attractiveness Analysis by Application, 2022-2032

Figure 67: East Asia Market Attractiveness Analysis by End User, 2022-2032

Figure 68: East Asia Market Attractiveness Analysis by Country, 2022-2032

Figure 69: Oceania Market Value Analysis (US$ Mn), 2017-2021

Figure 70: Oceania Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032

Figure 71: Oceania Market Share, By Modality (2022)

Figure 72: Oceania Market Share, By End User (2022)

Figure 73: Oceania Market Share, By Application (2022)

Figure 74: Oceania Market Share, By Country (2022)

Figure 75: Oceania Market Attractiveness Analysis by Modality, 2022-2032

Figure 76: Oceania Market Attractiveness Analysis by Application, 2022-2032

Figure 77: Oceania Market Attractiveness Analysis by End User, 2022-2032

Figure 78: Oceania Market Attractiveness Analysis by Country, 2022-2032

Figure 79: Middle East and Africa Market Value Analysis (US$ Mn), 2017-2021

Figure 80: Middle East and Africa Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032

Figure 81: Middle East and Africa Market Share, By Modality (2022)

Figure 82: Middle East and Africa Market Share, By End User (2022)

Figure 83: Middle East and Africa Market Share, By Application (2022)

Figure 84: Middle East and Africa Market Share, By Country (2022)

Figure 85: Middle East and Africa Market Attractiveness Analysis by Modality, 2022-2032

Figure 86: Middle East and Africa Market Attractiveness Analysis by Application, 2022-2032

Figure 87: Middle East and Africa Market Attractiveness Analysis by End User, 2022-2032

Figure 88: Middle East and Africa Market Attractiveness Analysis by Country, 2022-2032

Figure 89: U.S Market Value Proportion Analysis, 2022

Figure 90: Global Vs. U.S Growth Comparison

Figure 91: U.S. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 92: U.S. Market Share Analysis (%) By Application, 2022 & 2032

Figure 93: U.S. Market Share Analysis (%) By End User, 2022 & 2032

Figure 94: Canada Market Value Proportion Analysis, 2022

Figure 95: Global Vs. Canada Growth Comparison

Figure 96: Canada. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 97: Canada. Market Share Analysis (%) By Application, 2022 & 2032

Figure 98: Canada. Market Share Analysis (%) By End User, 2022 & 2032

Figure 99: Mexico Market Value Proportion Analysis, 2022

Figure 100: Global Vs. Mexico Growth Comparison

Figure 101: Mexico. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 102: Mexico. Market Share Analysis (%) By Application, 2022 & 2032

Figure 103: Mexico. Market Share Analysis (%) By End User, 2022 & 2032

Figure 104: Brazil Market Value Proportion Analysis, 2022

Figure 105: Global Vs. Brazil Growth Comparison

Figure 106: Brazil. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 107: Brazil. Market Share Analysis (%) By Application, 2022 & 2032

Figure 108: Brazil. Market Share Analysis (%) By End User, 2022 & 2032

Figure 109: U.K. Market Value Proportion Analysis, 2022

Figure 110: Global Vs. U.K. Growth Comparison

Figure 111: U.K. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 112: U.K. Market Share Analysis (%) By Application, 2022 & 2032

Figure 113: U.K. Market Share Analysis (%) By End User, 2022 & 2032

Figure 114: Germany Market Value Proportion Analysis, 2022

Figure 115: Global Vs. Germany Growth Comparison

Figure 116: Germany. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 117: Germany. Market Share Analysis (%) By Application, 2022 & 2032

Figure 118: Germany. Market Share Analysis (%) By End User, 2022 & 2032

Figure 119: France Market Value Proportion Analysis, 2022

Figure 120: Global Vs. France Growth Comparison

Figure 121: France. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 122: France. Market Share Analysis (%) By Application, 2022 & 2032

Figure 123: France. Market Share Analysis (%) By End User, 2022 & 2032

Figure 124: Italy Market Value Proportion Analysis, 2022

Figure 125: Global Vs. Italy Growth Comparison

Figure 126: Italy. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 127: Italy. Market Share Analysis (%) By Application, 2022 & 2032

Figure 128: Italy. Market Share Analysis (%) By End User, 2022 & 2032

Figure 129: Spain Market Value Proportion Analysis, 2022

Figure 130: Global Vs. Spain Growth Comparison

Figure 131: Spain. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 132: Spain. Market Share Analysis (%) By Application, 2022 & 2032

Figure 133: Spain. Market Share Analysis (%) By End User, 2022 & 2032

Figure 134: Russia Market Value Proportion Analysis, 2022

Figure 135: Global Vs. Russia Growth Comparison

Figure 136: Russia. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 137: Russia. Market Share Analysis (%) By Application, 2022 & 2032

Figure 138: Russia. Market Share Analysis (%) By End User, 2022 & 2032

Figure 139: BENELUX Market Value Proportion Analysis, 2022

Figure 140: Global Vs. BENELUX Growth Comparison

Figure 141: BENELUX. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 142: BENELUX. Market Share Analysis (%) By Application, 2022 & 2032

Figure 143: BENELUX. Market Share Analysis (%) By End User, 2022 & 2032

Figure 144: Poland Market Value Proportion Analysis, 2022

Figure 145: Global Vs. Poland Growth Comparison

Figure 146: Poland. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 147: Poland. Market Share Analysis (%) By Application, 2022 & 2032

Figure 148: Poland. Market Share Analysis (%) By End User, 2022 & 2032

Figure 149: China Market Value Proportion Analysis, 2022

Figure 150: Global Vs. China Growth Comparison

Figure 151: China. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 152: China. Market Share Analysis (%) By Application, 2022 & 2032

Figure 153: China. Market Share Analysis (%) By End User, 2022 & 2032

Figure 154: Japan Market Value Proportion Analysis, 2022

Figure 155: Global Vs. Japan Growth Comparison

Figure 156: Japan. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 157: Japan. Market Share Analysis (%) By Application, 2022 & 2032

Figure 158: Japan. Market Share Analysis (%) By End User, 2022 & 2032

Figure 159: South Korea Market Value Proportion Analysis, 2022

Figure 160: Global Vs. South Korea Growth Comparison

Figure 161: South Korea. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 162: South Korea. Market Share Analysis (%) By Application, 2022 & 2032

Figure 163: South Korea. Market Share Analysis (%) By End User, 2022 & 2032

Figure 164: India Market Value Proportion Analysis, 2022

Figure 165: Global Vs. India Growth Comparison

Figure 166: India. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 167: India. Market Share Analysis (%) By Application, 2022 & 2032

Figure 168: India. Market Share Analysis (%) By End User, 2022 & 2032

Figure 169: ASEAN Market Value Proportion Analysis, 2022

Figure 170: Global Vs. ASEAN Growth Comparison

Figure 171: ASEAN. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 172: ASEAN. Market Share Analysis (%) By Application, 2022 & 2032

Figure 173: ASEAN. Market Share Analysis (%) By End User, 2022 & 2032

Figure 174: Australia Market Value Proportion Analysis, 2022

Figure 175: Global Vs. Australia Growth Comparison

Figure 176: Australia. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 177: Australia. Market Share Analysis (%) By Application, 2022 & 2032

Figure 178: Australia. Market Share Analysis (%) By End User, 2022 & 2032

Figure 179: New Zealand Market Value Proportion Analysis, 2022

Figure 180: Global Vs. New Zealand Growth Comparison

Figure 181: New Zealand. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 182: New Zealand. Market Share Analysis (%) By Application, 2022 & 2032

Figure 183: New Zealand. Market Share Analysis (%) By End User, 2022 & 2032

Figure 184: GCC Countries Market Value Proportion Analysis, 2022

Figure 185: Global Vs. GCC Countries Growth Comparison

Figure 186: GCC Countries. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 187: GCC Countries. Market Share Analysis (%) By Application, 2022 & 2032

Figure 188: GCC Countries. Market Share Analysis (%) By End User, 2022 & 2032

Figure 189: South Africa Market Value Proportion Analysis, 2022

Figure 190: Global Vs. South Africa Growth Comparison

Figure 191: South Africa. Market Share Analysis (%) By Modality, 2022 & 2032

Figure 192: South Africa. Market Share Analysis (%) By Application, 2022 & 2032

Figure 193: South Africa. Market Share Analysis (%) By End User, 2022 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Molecular Quality Controls Market

Published : February 2022

Healthcare

Molecular Biomarkers For Cancer Detection Market

Published : September 2016

Healthcare

Molecular Diagnostics Market

Published : February 2016

Healthcare

Molecular Spectroscopy Market

Published : July 2020

Google translate

Molecular Imaging Market